Viz.ai Launches AI-Powered Vascular Imaging Software

An emerging artificial intelligence (AI) software, which can be utilized with multiple imaging modalities, may enhance the assessment and timely care coordination for vascular conditions, including aortic dissection and pulmonary embolism.

The recently launched Viz Vascular Suite can be utilized with a variety of imaging modalities, including computed tomography (CT) and echocardiography, to provide automated analysis of suspected vascular conditions, according to the software’s manufacturer Viz.ai.

After a vascular condition has been identified, Viz.ai said the Viz Vascular Suite software app sends alerts and patient imaging scans via HIPAA-compliant means to the mobile devices of providers. Philip Batista, M.D., emphasized the ability of the Viz Vascular Suite to foster timely notification and interdisciplinary care for patients with serious vascular conditions.

“When Viz identifies an abnormal scan, it quickly notifies the appropriate specialists regardless of their location, facilitating seamless communication via mobile application,” noted Dr. Batista, an assistant professor of surgery and associate program director of Vascular and Endovascular Surgery Residency at the Cooper Medical School of Rowan University in Camden, N.J. “We’ve been using the Viz software for the last several months and have seen improvements in patient care across our institution.”

(Editor’s note: For related articles, see “AI-Powered Algorithm May Enhance CT Assessment of Aortic Dissection,” “Pie Medical Imaging Launches AI-Powered Echocardiography Platform” and “FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.”)